First Time Loading...

Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 125 JPY -0.43%
Updated: May 2, 2024

Takeda Pharmaceutical Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Takeda Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
4568
4578
4523
4519
4503

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Financing Activities
-¥302.8B
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Financing Activities
-¥123.5B
CAGR 3-Years
4%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Cash from Financing Activities
-¥60.3B
CAGR 3-Years
17%
CAGR 5-Years
8%
CAGR 10-Years
2%
Eisai Co Ltd
TSE:4523
Cash from Financing Activities
-¥39.8B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
10%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Financing Activities
-¥139.3B
CAGR 3-Years
-12%
CAGR 5-Years
-32%
CAGR 10-Years
-20%
Astellas Pharma Inc
TSE:4503
Cash from Financing Activities
¥478.6B
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Takeda Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-302.8B JPY

Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -302.8B JPY.

What is Takeda Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
29%

Over the last year, the Cash from Financing Activities growth was 68%. The average annual Cash from Financing Activities growth rates for Takeda Pharmaceutical Co Ltd have been 29% over the past three years .